Literature DB >> 7657828

Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.

K Ikewaki1, M Nishiwaki, T Sakamoto, T Ishikawa, T Fairwell, L A Zech, M Nagano, H Nakamura, H B Brewer, D J Rader.   

Abstract

The cholesteryl ester transfer protein (CETP) transfers lipids among lipoprotein particles and plays a central role in lipoprotein metabolism. Humans with genetic deficiency of CETP have both elevated HDL cholesterol and apolipoprotein A-I concentrations as well as decreased LDL cholesterol and apolipoprotein B levels. The present study was undertaken to elucidate the metabolic basis for the decreased LDL cholesterol and apo B levels in CETP deficiency. We conducted a series of in vivo apo B kinetic studies in tow unrelated homozygotes with CETP deficiency and in control subjects. A primed constant infusion of stable isotopically labeled phenylalanine was administered to the two CETP deficient subjects and control subjects and apo B kinetic parameters in VLDL, intermediate density lipoproteins, and LDL were obtained by using a multicompartmental model. The fractional catabolic rates (FCR) of LDL apo B were significantly increased in the CETP-deficient subjects (0.56 and 0.75/d) compared with the controls (mean FCR of 0.39/d). Furthermore, the production rates of apo B in VLDL and intermediate density lipoprotein were decreased by 55% and 81%, respectively, in CETP deficiency compared with the controls. In conclusion, CETP-deficient subjects were demonstrated to have substantially increased catabolic rates of LDL apo B as the primary metabolic basis for the low plasma levels of LDL apo B. This result indicates that the LDL receptor pathway may be up-regulated in CETP deficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657828      PMCID: PMC185783          DOI: 10.1172/JCI118196

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

Review 2.  Plasma cholesteryl ester transfer protein.

Authors:  A R Tall
Journal:  J Lipid Res       Date:  1993-08       Impact factor: 5.922

3.  Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.

Authors:  S Venkatesan; P Cullen; P Pacy; D Halliday; J Scott
Journal:  Arterioscler Thromb       Date:  1993-07

Review 4.  Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data.

Authors:  D M Foster; P H Barrett; G Toffolo; W F Beltz; C Cobelli
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

5.  Comparison of current methods for high-density lipoprotein cholesterol quantitation.

Authors:  G R Warnick; M C Cheung; J J Albers
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

6.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; D J Rader; T Sakamoto; M Nishiwaki; N Wakimoto; J R Schaefer; T Ishikawa; T Fairwell; L A Zech; H Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species.

Authors:  Y C Ha; P J Barter
Journal:  Comp Biochem Physiol B       Date:  1982

8.  Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.

Authors:  D J Rader; W Cain; L A Zech; D Usher; H B Brewer
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles.

Authors:  X C Jiang; L Masucci-Magoulas; J Mar; M Lin; A Walsh; J L Breslow; A Tall
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

10.  Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes.

Authors:  M Tanaka; H Jingami; H Otani; M Cho; Y Ueda; H Arai; Y Nagano; T Doi; M Yokode; T Kita
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

View more
  10 in total

1.  The inhibition of cholesteryl ester transfer protein: a long and winding road.

Authors:  Kerry-Anne Rye; Philip J Barter
Journal:  J Lipid Res       Date:  2012-04-10       Impact factor: 5.922

Review 2.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

Review 3.  In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease.

Authors:  Katsunori Ikewaki
Journal:  Clin Exp Nephrol       Date:  2013-10-16       Impact factor: 2.801

4.  Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

Authors:  John S Millar; Gissette Reyes-Soffer; Patricia Jumes; Richard L Dunbar; Emil M deGoma; Amanda L Baer; Wahida Karmally; Daniel S Donovan; Hashmi Rafeek; Laura Pollan; Junichiro Tohyama; Amy O Johnson-Levonas; John A Wagner; Stephen Holleran; Joseph Obunike; Yang Liu; Rajasekhar Ramakrishnan; Michael E Lassman; David E Gutstein; Henry N Ginsberg; Daniel J Rader
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

Review 5.  Human genetics of variation in high-density lipoprotein cholesterol.

Authors:  Atif Qasim; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

Review 6.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 7.  Trials and Tribulations of CETP Inhibitors.

Authors:  Alan R Tall; Daniel J Rader
Journal:  Circ Res       Date:  2017-10-10       Impact factor: 17.367

Review 8.  High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.

Authors:  Navin K Kapur; Dominique Ashen; Roger S Blumenthal
Journal:  Vasc Health Risk Manag       Date:  2008

9.  Computational lipidology: predicting lipoprotein density profiles in human blood plasma.

Authors:  Katrin Hübner; Thomas Schwager; Karl Winkler; Jens-Georg Reich; Hermann-Georg Holzhütter
Journal:  PLoS Comput Biol       Date:  2008-05-23       Impact factor: 4.475

10.  An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway.

Authors:  James Lu; Katrin Hübner; M Nazeem Nanjee; Eliot A Brinton; Norman A Mazer
Journal:  PLoS Comput Biol       Date:  2014-03-13       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.